Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Monopar Therapeutics Inc (MNPR)

Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Monopar Therapeutics Inc 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 USA

www.monopartx.com Employees: 10 P: 847-388-0349

Description:

Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.

Key Statistics

Overview:

Market Capitalization, $K 136,273
Enterprise Value, $K 129,003
Shares Outstanding, K 5,278
Annual Sales, $ 0 K
Annual Net Income, $ -8,400 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,300 K
EBIT, $ -6,990 K
EBITDA, $ -6,990 K
60-Month Beta 1.23
% of Insider Shareholders 34.90%
% of Institutional Shareholders 1.83%
Float, K 3,436
% Float 65.10%
Short Volume Ratio 0.50

Growth:

1-Year Return 1,165.38%
3-Year Return 54.61%
5-Year Return -73.91%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/08/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -1.97
EPS Growth vs. Prev Qtr 26.00%
EPS Growth vs. Prev Year 47.14%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 08/13/24

MNPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.21%
Return-on-Assets % -87.57%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 19.05
Book Value/Share 1.25
Interest Coverage -1.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar